Microchip Technology Incorporated

Microchip Technology Incorporated Q2 2027 Earnings Recap

MCHP Q2 2027 Published November 7, 2026

Get alerts when MCHP reports next quarter

Set up alerts — free

Microchip shares fell 10.0% after earnings, with the outlook likely disappointing investors: December-quarter sales are expected to decline sequentially, and September revenue included $53 million of items not expected to recur. That makes the reported growth and above-guidance EPS less indicative of the underlying near-term trend.

Earnings Per Share Beat
$0.97 vs $0.94 est.
+3.6% surprise
Revenue Beat
1621500000 vs 1608852000 est.
+0.8% surprise

Market Reaction

Post-Earnings -10.02%

See MCHP alongside your other holdings

Add to your portfolio — free

Key Takeaways

  • September-quarter net sales were $1.622 billion, up 9.2% sequentially and 42.2% year over year; non-GAAP EPS was $0.97, $0.04 above the midpoint of guidance.
  • About $53 million of September sales came from infrequent items: a $21 million channel-pricing impact, $22 million of patent-licensing revenue above the expected December-quarter level, and a $10 million long-term-contract benefit.
  • Non-GAAP gross margin was 66.5%, including $26.6 million of capacity-underutilization charges; the company said licensing revenue and the pricing change lifted the margin.
  • Growth was broad across reported end markets, led by data center, up 55.7% year over year, and industrial, up 50.3%. Data center sales exceeded $250 million in the quarter.
  • Inventory rose to $1.117 billion, or 184 days, up nine days sequentially. The company cited incoming wafers and finished-goods builds.
This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit MCHP on AllInvestView.

Get the Full Picture on MCHP

Track Microchip Technology Incorporated in your portfolio with real-time analytics, dividend tracking, and more.

View MCHP Analysis